Lives saved and lost in the first six month of the US COVID-19 pandemic: A retrospective cost-benefit analysis
Covid
Patient infected with COVID-19 finally cured after 411 days
Does Tenofovir Disoproxil Fumarate Mitigate COVID-19 Outcomes in Men with HIV?
Tenofovir and COVID: The Jury Is Still Out
Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
‘Old style’ tenofovir really may protect against COVID, large US study finds
Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV
Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B - BMC Infectious Diseases
Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients - BMC Infectious Diseases
Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study - BMC Infectious Diseases
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study
SARS-Cov-2 Associated Neurocognitive Decline (SAND) Scan
Murphy's Medicine Podcast: Episode One. SARS CoV2 Associated Neurocognitive Decline
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
Dose matters: HIV drug could prevent coronaviruses, study finds
Research shows how HIV drug could stop many coronavirus diseases
Common HIV medication associated with improved COVID-19 outcomes
CURE-ID
(3) Salvatore Mattera on X: "A friend of mine who is a physician told me about CURE ID. It's a database that uses the experiences of long COVID patients to try to find off label drugs for treatment. They're trying to get more people enrolled. You can check it out here: https://t.co/0BAUPlILr6" / X
COVID, Capitalism, and Class War, Vol. 1
Myocarditis complications more common after COVID infection than vaccination, 18-month data suggest | CIDRAP
Meta CEO Says He Was ‘Pressured’ by Biden to Pull Covid Content
COVID's Spike Protein Enhances Ability to Infect Brain - Neuroscience News
New vector vaccine against COVID-19 provides long-term protection